Use and Toxicity of Checkpoint Inhibitors for Solid Tumor Treatment in a Veteran Population
Pediatric News ,
1. OPDIVO (nivolumab) injection, for intravenous infusion. Package Insert. Princeton, NJ: Bristol-Myers Squibb Company; 2014.
1. OPDIVO (nivolumab) injection, for intravenous infusion. Package Insert. Princeton, NJ: Bristol-Myers Squibb Company; 2014.
HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- ("Moleculin" or the "Company"), a clinical-stage pharmaceutical company focused on…
HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical-sta…
HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a clinical-stag…